| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Rilotumumab |
➤ Sign Up |
Multispecific constructs |
AbbVie Stemcentrx LLC (North Chicago, IL) |
➤ Sign Up |
| Rilotumumab |
➤ Sign Up |
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
CureVac AG (Tubingen, DE) |
➤ Sign Up |
| Rilotumumab |
➤ Sign Up |
P97 fragments with transfer activity |
biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) |
➤ Sign Up |
| Rilotumumab |
➤ Sign Up |
Meditopes and meditope-binding antibodies and uses thereof |
City of Hope (Duarte, CA) |
➤ Sign Up |
| Rilotumumab |
➤ Sign Up |
Fragments of p97 and uses thereof |
biOasis Technologies, Inc. (Richmond, CA) |
➤ Sign Up |
| Rilotumumab |
➤ Sign Up |
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
CureVac AG (Tubingen, DE) |
➤ Sign Up |
| Rilotumumab |
➤ Sign Up |
Anti-CD324 monoclonal antibodies and uses thereof |
ABBVIE STEMCENTRX LLC (North Chicago, IL) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
